Creative Medical Technology Holdings, Inc. Total Liabilities and Equity
Creative Medical Technology Holdings, Inc. (CELZ) had Total Liabilities and Equity of $9.38 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-07
- 2026-06-30: Liabilities and Equity $9.38M.
- 2026-03-31: Liabilities and Equity $6.44M.
- 2025-12-31: Liabilities and Equity $7.81M.
- 2025-09-30: Liabilities and Equity $5.85M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $9.38M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $6.44M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $7.81M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $5.85M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $7.11M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $8.35M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $6.67M 10-K · filed 2026-03-20 | |
| 2024-09-30 | $6.89M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $7.99M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $9.62M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $10.72M 10-K · filed 2025-03-14 | |
| 2023-09-30 | $12.51M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $14.13M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $15.23M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $19.19M 10-K · filed 2024-03-22 | |
| 2022-09-30 | $22.47M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $23.43M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $9.73M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $11.27M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $3.13M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $732.31K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $871.88K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $717.77K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $425.24K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $442.93K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $469.31K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $530.80K 10-K · filed 2021-03-17 | |
| 2019-09-30 | $330.38K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $358.05K 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $577.86K 10-Q · filed 2019-05-20 | |
| 2018-12-31 | $477.16K 10-K · filed 2020-04-06 | |
| 2018-09-30 | $355.62K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $279.38K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $291.27K 10-Q · filed 2018-08-03 | |
| 2017-12-31 | $203.15K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $211.15K 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $299.62K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $196.13K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $322.51K 10-K · filed 2018-03-29 | |
| 2016-09-30 | $136.74K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $121.68K 10-Q · filed 2016-08-19 | |
| 2016-03-31 | $216.00 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $49.60K 10-K · filed 2017-02-13 | $216.00 10-K · filed 2016-04-14 |
| 2015-09-30 | $741.00 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $641.00 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $583.00 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $954.00 10-K · filed 2016-04-14 | |
| 2014-09-30 | $1.29K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $1.29K 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $1.29K 10-Q · filed 2014-05-13 | |
| 2013-12-31 | $374.00 10-K · filed 2015-02-27 | |
| 2013-09-30 | $398.00 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $403.00 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $1.78K 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $1.57K 10-K · filed 2014-03-17 | |
| 2012-09-30 | $1.15K 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $531.00 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $1.63K 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $3.10K 10-K · filed 2013-03-15 | |
| 2011-09-30 | $4.21K 10-Q · filed 2011-10-31 | |
| 2011-06-30 | $400.00 10-Q/A · filed 2011-08-25 | |
| 2010-12-31 | $414.00 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |